Palmar plantar erythrodysesthesia physical examination: Difference between revisions
Mahshid |
No edit summary |
||
Line 3: | Line 3: | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
At its maximal severity the condition can cause bullous, ulcerative or even erosive condition.<ref name="pmid17101468">{{cite journal| author=Janusch M, Fischer M, Marsch WCh, Holzhausen HJ, Kegel T, Helmbold P| title=The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy. | journal=Eur J Dermatol | year= 2006 | volume= 16 | issue= 5 | pages= 494-9 | pmid=17101468 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17101468 }}</ref> | |||
==References== | ==References== |
Revision as of 13:09, 14 October 2018
Palmar plantar erythrodysesthesia Microchapters |
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
---|
Diagnosis |
Treatment |
Palmar plantar erythrodysesthesia physical examination On the Web |
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia physical examination |
FDA on Palmar plantar erythrodysesthesia physical examination |
CDC on Palmar plantar erythrodysesthesia physical examination |
Palmar plantar erythrodysesthesia physical examination in the news |
Blogs on Palmar plantar erythrodysesthesia physical examination |
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Risk calculators and risk factors for Palmar plantar erythrodysesthesia physical examination |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
At its maximal severity the condition can cause bullous, ulcerative or even erosive condition.[1]
References
- ↑ Janusch M, Fischer M, Marsch WCh, Holzhausen HJ, Kegel T, Helmbold P (2006). "The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy". Eur J Dermatol. 16 (5): 494–9. PMID 17101468.